By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Mundipharma AG 

St. Alban-Rheinweg 74

Basel    CH-4006  Switzerland
Phone: 41-61-2051112 Fax: 41-61-2051109



Company News
Mundipharma AG And Medical Developments International Announce A New Alliance For The Commercialisation Of Penthrox In Europe 9/14/2015 12:44:26 PM
Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) Could Bank $1 Billion From Mundipharma AG, Purdue Pharma L.P. Pain Pact 1/12/2015 6:04:11 AM
Mundipharma AG Receives Positive European Commission Decision On Targin® (Oxycodone/Naloxone) For The Treatment Of Restless Legs Syndrome 1/7/2015 10:38:43 AM
Mundipharma AG Receives Positive CHMP Opinion For Targin® (Oxycodone / Naloxone) For The Treatment Of Restless Legs Syndrome1 10/24/2014 10:56:59 AM
Mundipharma AG Presents Four Posters On “Pain Management In Asia” At The International Association For The Study Of Pain’s 15th World Congress On Pain In Buenos Aires, Argentina 10/6/2014 10:38:43 AM
Skyepharma PLC (SKYEF)’s Partner Mundipharma AG Announces Results Of Pivotal Phase III Study For Flutiform® In Paediatric Asthma 9/8/2014 9:11:21 AM
SkyePharma Inc. (SKYE) Release: Flutiform® Launched In France €3 Million Milestone Receivable From Mundipharma AG 2/10/2014 9:34:03 AM
Mundipharma AG Research Becomes The Latest Pharmaceutical Company To Choose BioClinica, Inc.'s Industry-Leading Clinical Trial Management System 1/28/2014 11:04:16 AM
Hong Kong Authority Approves Mundipharma AG's Flutiform® (fluticasone propionate/formoterol fumarate), a New Treatment for Asthma 11/8/2013 7:15:07 AM
SkyePharma Inc. (SKYE) Release: flutiform® Launch in Italy Triggers €2 Million Milestone From Marketing Partner Mundipharma AG 6/20/2013 8:49:52 AM